REGISTERED NUMBER: 13294927 (England and Wales)

VARMA DERMATOLOGY LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Dr K Varma

Dr M C Varma

REGISTERED OFFICE:

Cashs Business Centre 1st Floor

228 Widdrington Road

Coventry

West Midlands

CV1 4PB

REGISTERED NUMBER:

13294927 (England and Wales)

ACCOUNTANTS:

Shah & Co (Accountants) Ltd

Chartered Certified Accountants

Cash's Business Centre

1st Floor

228 Widdrington Road

Coventry

West Midlands

CV1 4PB

FIXED ASSETS

Tangible assets

4

1,433

1,345

Investment property

5

419,546

419,546

420,979

420,891

CURRENT ASSETS

Debtors

6

26,500

21,000

Cash at bank

32,320

39,380

58,820

60,380

CREDITORS

Amounts falling due within one year

7

(32,024

)

(82,689

)

NET CURRENT ASSETS/(LIABILITIES)

26,796

(22,309

)

TOTAL ASSETS LESS CURRENT LIABILITIES

447,775

398,582

CAPITAL AND RESERVES

Called up share capital

300

300

Retained earnings

447,475

398,282

447,775

398,582

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by:

Dr M C Varma - Director

1.	STATUTORY INFORMATION

Varma Dermatology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

15% on reducing balance

Computer equipment

-

33% on cost

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Computer

fittings

equipment

Totals

£

£

£

COST

At 1 April 2024

1,465

1,412

2,877

Additions

-

999

999

At 31 March 2025

1,465

2,411

3,876

DEPRECIATION

At 1 April 2024

566

966

1,532

Charge for year

135

776

911

At 31 March 2025

701

1,742

2,443

NET BOOK VALUE

At 31 March 2025

764

669

1,433

At 31 March 2024

899

446

1,345

5.	INVESTMENT PROPERTY

Total

£

FAIR VALUE

At 1 April 2024

and 31 March 2025

419,546

NET BOOK VALUE

At 31 March 2025

419,546

At 31 March 2024

419,546

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Other debtors

26,500

21,000

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Tax

25,749

79,936

Directors' current accounts

4,477

954

Accrued expenses

1,798

1,799

32,024

82,689

8.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

Included within other creditors is £4,477 (2024: £954) owed to the directors. The amount is unsecured and interest fess with no set terms for repayment.

9.	RELATED PARTY DISCLOSURES

Dividends paid to Dr K Varma in her capacity as a shareholder (A ordinary) of the company totalled £500. Dividends also paid to the shareholders of B ordinary shares totalled £29,500. No dividends were paid to the share holders of ordinary shares.

10.	ULTIMATE CONTROLLING PARTY

The ultimate controlling parties are Messers Dr K Varman and Dr M C Varma.